SV3DPrinter’s vision for future 3D printers
According to The 2019 purmundus challenge,” which is being held from 19 to 22 November 2019 in Frankfurt in hall 12.1-E09 of the Formnext trade fair, shines a spotlight on forward-looking product ideas from 18 countries on 5 continents under the motto “Beyond 3D printing. This is the seventh time that the 3D and 4D printing award for the purmundus challenge has been presented in Frankfurt. A total of 38 finalists now stand a chance of winning the prestigious purmundus challenge trophy. The award ceremony will be broadcast live from the Formnext exhibition via the Facebook portal. In addition to the first three places, this year there will once again be a “special mention” and an “innovation prize”. A prize for the “people’s choice”, voted for over the course of the fair by visitors to Formnext 2019, completes the purmundus challenge.
International exhibition and conference on 3D printing / additive manufacturing & tooling (19-22 Nov 2019).
According to A. Fatih Sarioglu, an assistant professor in Georgia Tech’s School of Electrical and Computer Engineering (ECE)“Isolating circulating tumor cells from whole blood samples has been a challenge because we are looking for a handful of cancer cells mixed with billions of normal red and white blood cells. With this device, we can process a clinically-relevant volume of blood by capturing nearly all of the white blood cells and then filtering out the red blood cells by size. That leaves us with undamaged tumor cells that can be sequenced to determine the specific cancer type and the unique characteristics of each patient’s tumor.”
According to Pankaj Karande, an associate professor of chemical and biological engineering and a member of the Center for Biotechnology and Interdisciplinary Studies (CBIS), who led this research at Rensselaer, “Right now, whatever is available as a clinical product is more like a fancy Band-Aid. It provides some accelerated wound healing, but eventually it just falls off; it never really integrates with the host cells.”